UpToDate Lexidrug
75
Quality Score
Strong
UpToDate Lexidrug
by Lexi-Comp
Medium confidence
✍️ Bumetric analysis
“
UpToDate Lexidrug is an iOS app from Lexi-Comp in the Education category, currently rated 4.7★ across 3,667 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 75: Strong (healthy traction). For a Education app, that means healthy traction. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$9.6K
per month
→
12-mo forecast
$9.9K – $20.8K
per month
→
24-mo forecast
$12.3K – $37.0K
per month
MID tierSUBSCRIPTION
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
142 snapshots on record
Rating
4.7
Reviews
3,667 reviews
Forecast Revenue / mo
$9.6K
Snapshots tracked
142
since Jun 2009
ONE-TIME · BUILD
💰 Estimated build cost
$175K
↳ What it cost to build · not monthly revenue
Likely range $130K – $235K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Pays back in ~1.5y at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (67 MB) | +$6K |
| ⚙ Education complexity ×1.20 | +$11K |
| ⚙ 17.3y maintenance × ~1-person team | +$103K |
Total estimate
$175K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$200K
↳ What it would sell for · not monthly revenue
Marketplace range $150K – $275K · 22× MRR multiple
💸
~1.1× build cost (break-even+)
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| 📅 17.3y proven track record | +20% |
| ⭐ ★ rating ≥ 4.7 (premium) | +15% |
| 🏷 Education category multiple | +6% |
Final multiple
22× MRR
👥 Estimated audience size
215K
Lifetime downloads (US-equivalent)
Monthly active
7.7K
Daily active
2.3K
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
How we sized it
| 📲 Education engagement | ~85 installs / rating |
| 📅 17.3y of rating accumulation | -30% |
| 🔁 Education D30 retention | 18% |
| 📍 DAU / MAU stickiness | 0.30 |
DAU / MAU
30% sticky
🛠 Estimated tech stack
🍎
Native iOS (Swift / UIKit)
Medium confidence · 70%
Also possible
Flutter
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
Signals we read
| 📦 App bundle size | 67 MB |
| 🏷 Category context | Education |
| 📦 Small-mid iOS bundle | → Native Swift / UIKit (pre-2020 era) |
💀 Maintenance status
Active
15%
Last shipped 2026-07-22 · 72 days ago
0 · Active
50 · At risk
100 · Abandoned
Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.
Risk signals
| 📅 72 days since last update | Healthy release cadence |
Verdict
Active
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$9.6K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
Direction
Tailwinds: monetization model proven
6 months
$9.1K – $15.2K
12 months
$9.9K – $20.8K
24 months
$12.3K – $37.0K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Below median · 50/100MID TIERSUBSCRIPTIONunderperforming peersGrowth Velocity
5.0
Founder Strength
5.2
Product Quality
7.0
Revenue Strength
4.0
Monetization Maturity
9.5
Defensibility
7.0
Market Position
2.0
Operational Safety
0.0
- 💰 Revenue: Modest — $6K - $14K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.72★ across 3,667 reviews — solid.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: High — 15% subscription complaints, scam/fraud mentions detected, bug mentions above category norm.
🎯 For competitors: Vulnerable. Quality drift + slow updates create a clear opening for a fresh competitor with active dev cadence.
💵 For acquirers: Estimated asking range 12-22× monthly = $115K-$211K. Discount applied for operational risk..
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 15 of 15 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| subscriptionREVIEW | +$2,500 | |
| Excellent rating (4.7★)METRIC | +$2,200 | |
| bugsREVIEW | −$1,800 | |
| 5 starREVIEW | +$1,800 | |
| cancelledREVIEW | −$1,500 | |
| excellent appREVIEW | +$1,500 | |
| Low install base (3,667 ratings)METRIC | +$1,500 | |
| Mature app (17y old)METRIC | +$1,500 | |
| Multilingual (13 languages)METRIC | +$1,500 | |
| highly recommendREVIEW | +$1,400 | |
| slowREVIEW | −$1,200 | |
| free trialREVIEW | +$1,200 | |
| too expensiveREVIEW | −$1,000 | |
| priceyREVIEW | −$800 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v9.5.3
- Fixed "Interations" bug.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- UpToDate Lexidrug
- Developer
- Lexi-Comp
- Bundle ID
- com.lexi.Individual
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- AR, CS, EN, FR, DE, IT, JA, KO, MS, PL, PT, ZH, ES
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Reported revenue signal / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- Model estimate / mo
- $9.6K/mo
- Top-grossing rank
- 🇺🇸#18 /100 🇨🇦#22 /99 🇧🇷#59 /98
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth5,433 ratings+2672% lifetimeShow 3-year history estimate ▾
Tracked (60 weeks) Pre-tracking estimate (0 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Top Countries — Grossing Rank3 countries
🇺🇸US#18 /100
🇨🇦CA#22 /99
🇧🇷BR#59 /98
📊Category Rank Trajectory#18 now · best #18 · worst #84
Lower line = better rank · Estimate from ratings growth model · Lower position on chart = worse rank · Higher = top of chart
🚀Update Frequency · Releases per Quarter3 releases tracked
🚀Version Release Timeline3 releases tracked
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
UpToDate® Lexidrug™ is the preferred drug reference app, providing industry-leading drug information and tools that support safe and effective medication and therapeutic decisions.
View the latest clinical information updated daily by our unparalleled multidisciplinary editorial team that continually reviews the most current evidence available. Used and trusted by pharmacists, physicians, nurses, advanced practice nurses, dentists, and students as an invaluable referential resource.
Easily access Lexidrug content directly in the app without needing to download databases onto your device.… View full description on the official store →
View the latest clinical information updated daily by our unparalleled multidisciplinary editorial team that continually reviews the most current evidence available. Used and trusted by pharmacists, physicians, nurses, advanced practice nurses, dentists, and students as an invaluable referential resource.
Easily access Lexidrug content directly in the app without needing to download databases onto your device.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 67 MB🔞 17+📱 iOS 16.0+🔖 v9.5.3🔄 updated 2mo ago🌐 AR, CS, EN, FR, DE +8📂 Education💰 Paid🚀 Launched 2009 (17y old)
📅
What Worked™ · Development Pipeline
16 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-08
📈
Crossed 5,000 ratings — social-proof flywheel kicking in
→ 30 days after: reviews +375 high confidence
2026-07
🔧
Shipped update — v9.5.1 → v9.5.3
→ 30 days after: reviews +495 high confidence
2026-06
🔧
Shipped update — v9.4.2 → v9.5.1
→ 30 days after: revenue +$14.2K/mo · reviews +915 high confidence
2026-05
⭐
Rating ↑ 4.13 → 4.72 (improved 0.59★)
→ 30 days after: reviews +483 high confidence
2026-05
🔄
Monetization changed: paid → free
→ 30 days after: reviews +483 high confidence
2026-03
⭐
Rating ↑ 2.46 → 4.13 (improved 1.67★)
→ 30 days after: rating +1.67★ · reviews +2,759 high confidence
2026-03
📈
Crossed 500 ratings — social-proof flywheel kicking in
→ 30 days after: rating +1.67★ · reviews +2,759 high confidence
2013-11
📈
Crossed 100 ratings — social-proof flywheel kicking in
2012-01
📈
Crossed 50 ratings — social-proof flywheel kicking in
2010-11
⭐
Rating ↓ 3.95 → 3.20 (dropped 0.75★)
→ 30 days after: rating −0.07★ high confidence
2010-05
⭐
Rating ↓ 4.40 → 4.09 (dropped 0.31★)
2010-04
📈
Crossed 10 ratings — social-proof flywheel kicking in
→ 30 days after: rating −0.31★ high confidence
2009-06
⭐
Rating ↑ 3.00 → 3.67 (improved 0.67★)
→ 30 days after: rating +0.20★ medium · co-occurring
2009-06
🚀
First tracked snapshot — initial data captured
→ 30 days after: rating +0.20★ medium · co-occurring
2009-06
⭐
Rating ↑ 1.00 → 3.00 (improved 2.00★)
→ 30 days after: rating +0.20★ low · multiple changes
2009-06
🚀
First tracked snapshot — initial data captured
→ 30 days after: rating +0.20★ low · multiple changes
🗣
Voice of Customer
Based on 332 reviews across 4 markets● 53% positive · ● 15% neutral · ● 32% negative · Rating drift: -1.54★ (declining — recent 50: 3.18★ vs lifetime: 4.72★)
VADER compound sentiment per quarter (−1 = fully negative, +1 = fully positive). Each point ≥ 5 reviews.
Sentiment by country (−1 to +1)
🇬🇧 GB
+0.80
🇨🇦 CA
+0.22
🇺🇸 US
+0.18
🇧🇷 BR
+0.00
Top praise themes
please fix ×10 easy navigate ×5 drug info ×5 search bar ×3 drug information ×3 home screen ×3 update content ×3 fix asap ×3
Top complaint themes
please fix ×18 keeps crashing ×10 home screen ×9 free trial ×8 new version ×7 new update ×7 credit card ×7 wolters kluwer ×7
Risk signals
Refund mentions: 1.8% Subscription complaints: 15% Bug mentions: 25% Fraud / scam mentions: 0.6%
🌍
Multi-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 5★ | 3 | 5★ this version |
| 🇧🇷 BR | 4.46154★ | 39 | 4.46154★ this version |
| 🇨🇦 CA | 4.74346★ | 803 | 4.74346★ this version |
| 🇩🇪 DE | 3.71429★ | 7 | 3.71429★ this version |
| 🇫🇷 FR | 5★ | 3 | 5★ this version |
| 🇬🇧 GB | 4.3★ | 10 | 4.3★ this version |
| 🇮🇳 IN | 4.57407★ | 54 | 4.57407★ this version |
| 🇯🇵 JP | 5★ | 8 | 5★ this version |
| 🇺🇸 US | 4.73904★ | 5,545 | 4.73904★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for UpToDate Lexidrug: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
About this analysis
Why medium confidence: 3,667 ratings · no founder-verified revenue (model estimate only).
❓ Frequently Asked Questions
10 answers · auto-generated from this app's public dataHow much does UpToDate Lexidrug make per month?▴
Based on our ML-calibrated revenue forecast, UpToDate Lexidrug earns approximately $9.6K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
Is UpToDate Lexidrug profitable?▴
With estimated build cost $175K and monthly revenue $9.6K, UpToDate Lexidrug looks break-even-grade — payback period sits around 1.5 years. Profitability also depends on paid-acquisition spend and refund rate which the public model doesn't see.
How many users does UpToDate Lexidrug have?▴
Estimated audience: ~215K lifetime downloads, ~7K monthly active users, and ~2K daily active users. Derived from ratings count × category installs-per-rating × age decay. US-storefront-equivalent — global audience can be 5-10× larger for internationally-distributed apps.
What apps are like UpToDate Lexidrug?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
What is UpToDate Lexidrug built with?▴
Our heuristic places UpToDate Lexidrug on the Native iOS (Swift / UIKit) stack (Medium confidence, 70%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: Flutter.
Is UpToDate Lexidrug still actively maintained?▴
Maintenance status: Active (15% abandonment risk). Last shipped version was 2 months ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.
How much would UpToDate Lexidrug sell for?▴
Estimated acquisition value: $200K (marketplace range $150K – $275K). Calculated as 22× monthly revenue using the standard multiple for the detected monetization model + adjustments for age, rating quality and category demand. Calibrated against 2024-2026 Flippa / Acquire.com / MicroAcquire closed-deal medians.
When was UpToDate Lexidrug last updated?▴
UpToDate Lexidrug last shipped a new version on 2026-07-22 — 2 months ago. This is the date Apple / Google last accepted a new build, not a content-only push.
Who makes UpToDate Lexidrug?▴
UpToDate Lexidrug is published by Lexi-Comp on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is UpToDate Lexidrug's BU Score?▴
UpToDate Lexidrug has a BU Score of 75/100 (Strong). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.